MIMS news

Mirtazapine no more effective than placebo as an additive antidepressant

Mirtazapine no more effective than placebo as an additive antidepressant

Mirtazapine is unlikely to provide any clinical benefit...

New non-hormonal treatment for postmenopausal vaginal symptoms

New non-hormonal treatment for postmenopausal vaginal symptoms

Prescribers treating postmenopausal women with vulvar...

Pharmacists may be able to alter GP prescriptions in the event of a no-deal Brexit

Pharmacists may be able to alter GP prescriptions in the event of a no-deal Brexit

Pharmacists may need emergency powers to amend prescriptions...

Benzodiazepines and Z drugs linked to risk of Alzheimer's disease

Benzodiazepines and Z drugs linked to risk of Alzheimer's disease

Use of benzodiazepines and related drugs is associated...

NICE updates chronic heart failure guideline

NICE updates chronic heart failure guideline

NICE has updated its guideline on chronic heart failure...

New salmeterol/fluticasone breath-actuated inhaler for asthma and COPD

New salmeterol/fluticasone breath-actuated inhaler for asthma and COPD

Fusacomb Easyhaler (salmeterol/fluticasone) is a new...

Free MIMS diabetes workshops - last few places remaining

Free MIMS diabetes workshops - last few places remaining

Join MIMS at the 'Type 2 diabetes: getting to the heart...

Prescribing guidance 'not being followed' in older people with reduced kidney function

Prescribing guidance 'not being followed' in older people with reduced kidney function

Prescribing recommendations are not being applied to...

Gabapentin and pregabalin to be subject to tighter controls

Gabapentin and pregabalin to be subject to tighter controls

From April 2019 gabapentin and pregabalin will be reclassified...

Use of quinolone antibiotics should be restricted, says EMA

Use of quinolone antibiotics should be restricted, says EMA

The European Medicines Agency (EMA) has recommended...

Are you up to date with the latest inhalers?

Are you up to date with the latest inhalers?

View images and key features of inhalers and other...

Antidepressant withdrawal 'much greater problem than guidelines suggest'

Antidepressant withdrawal 'much greater problem than guidelines suggest'

The incidence, severity and duration of antidepressant...

New atypical antipsychotic offers potential benefits in treatment of schizophrenia

New atypical antipsychotic offers potential benefits in treatment of schizophrenia

Reagila (cariprazine) is an orally active partial agonist...

New morning sickness treatment available for women in the UK

New morning sickness treatment available for women in the UK

GPs can now prescribe the combination treatment Xonvea...

Fluticasone/formoterol asthma combination available in new device

Fluticasone/formoterol asthma combination available in new device

Flutiform K-haler (fluticasone/formoterol) is a new...

First in new class of migraine prophylactics launched

First in new class of migraine prophylactics launched

Erenumab (Aimovig) belongs to a new class of migraine...

Naloxone nasal spray: a new treatment option for opioid overdose

Naloxone nasal spray: a new treatment option for opioid overdose

Nyxoid (naloxone dihydrate) is a single-dose nasal...

Diclofenac significantly increases cardiovascular risk, large study suggests

Diclofenac significantly increases cardiovascular risk, large study suggests

The authors of a large-scale safety study of diclofenac...

Flu vaccines for 2018/19 season

Flu vaccines for 2018/19 season

Flu vaccine listings in MIMS have been updated for...

Fluad: new flu vaccine for older adults

Fluad: new flu vaccine for older adults

Adults aged 65 years and over can now be offered increased...